EMA Says It Is Evaluating Use Of COVID-19 Vaccine Moderna In Young People Aged 12 To 17
T-Reuters2021-06-08
European Medicines Agency:Ema Evaluating The Use Of Covid-19 Vaccine Moderna In Young People Aged 12 To 17.Ema Says Ewill Communicate The Outcome Of Moderna Vaccine Extension Evaluation, Which Is Expected In July Unless Supplementary Information Is Needed.Ema Says Covid-19 Vaccine Moderna Is Currently Authorised For Use In People Aged 18 And Older.Further Company Coverage: Mrna.O. ((Reuters.Briefs@Thomsonreuters.Com ;;)).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.